2025 annual financial data
Prelude Therapeutics 2025 Net income growth
Direct answer
Net income growth was 21.76%.
Operating income was -104,566,000 USD and net income was -99,498,000 USD.
Operating cash flow was -56,302,000 USD.
Get free Prelude Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,140,000 USD
- Operating income
- -104,566,000 USD
- Net income
- -99,498,000 USD
- Operating cash flow
- -56,302,000 USD